FDA approves ChoiceSpine for two new cervical spinal fusion devices — 3 insights

Written by Alan Condon | May 14, 2019 | Print  |

Knoxville, Tenn.-based spinal-device manufacturer, ChoiceSpine, has been granted FDA clearance to market two new devices, to be used together or separately in cervical spinal fusions.

The new technologies are the Tiger Shark C interbody device with BioBond technology and the Boomerang Anterior Cervical Plate.

Three insights:

1. Boomerang is a system of implants generated with a goal to simplify and enhance the efficiency of anterior cervical spinal fusions.

2. The device features a two-screw configuration and a single-step screw blocking tool for quick insertion and fixation of the anterior cervical spine.

3. Tiger Shark C is a 3D-manufactured titanium alloy cervical interbody device designed with BioBond technology, which is an organic, porous interbody architecture created for continuous porosity with an osteoconductive, hydrophilic surface.

ChoiceSpine is privately held by private equity firm Altus Capital Partners, which aims to make control investments exclusively in middle market manufacturing businesses.

More articles on devices:
Medtronic reaches 2nd ASC with newest Mazor edition — 3 highlights
FDA approves new spina bifida treatment that utilizes scopes
Innovasis HA PEEK Data Registry enrolls 150 patients

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months